• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在患有慢性肾病的儿科患者中,估计肾小球滤过率(eGFR)只能部分反映尿毒症毒素的蓄积。

Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease.

机构信息

Department of Paediatrics and Medical Genetics, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.

Department of Nephrology, Ghent University Hospital, Ghent, Belgium.

出版信息

Pediatr Nephrol. 2018 Feb;33(2):315-323. doi: 10.1007/s00467-017-3802-5. Epub 2017 Sep 22.

DOI:10.1007/s00467-017-3802-5
PMID:28939943
Abstract

BACKGROUND

Chronic kidney disease (CKD) in childhood is characterised by the accumulation of uraemic toxins resulting in a multisystem disorder that has a negative impact on quality of life. Childhood CKD is predominantly defined by a decrease in glomerular filtration rate, estimated (eGFR) by a single serum measurement of endogenous biomarkers, e.g. creatinine. The objective of this study was to evaluate how accurately eGFR predicts the concentration of uraemic toxins in a paediatric CKD cohort.

METHODS

In 65 children (10.8 [5.1; 14.7] years) with CKD (eGFR 44 [20; 64] mL/min/1.73 m), serum concentrations were determined of small solutes (uric acid [UA], urea, symmetric dimethylarginine [SDMA], asymmetric dimethylarginine [ADMA]), middle molecules (β2-microglobulin [β2M], complement factor D [CfD]) and protein-bound solutes (p-cresylglucuronide [pCG], hippuric acid, indole acetic acid, indoxyl sulphate [IxS], p-cresylsulfate [pCS] and 3-carboxy-4-methyl-5-propyl-furanpropionic acid [CMPF]). Spearman's correlation coefficients (r) were calculated to correlate uraemic toxin concentrations with three different eGFR equations, based on either serum creatinine or β2M.

RESULTS

Updated Schwartz eGFR was correlated reasonably well with concentrations of creatinine (r = -0.98), urea (r = -0.84), SDMA (r = -0.82) and middle molecules CfD and β2M (both r = -0.90). In contrast, poor correlation coefficients were found for CMPF (r = -0.32), UA (r = -0.45), ADMA (r = -0.47) and pCG (r = -0.48). The other toxins, all protein-bound, had r between -0.75 and -0.57. Comparable correlations were found between the three evaluated eGFR equations and uraemic toxin concentrations.

CONCLUSIONS

This study demonstrates that eGFR poorly predicts concentrations of protein-bound uraemic toxins, UA and ADMA in childhood CKD. Therefore, eGFR only partially reflects the complexity of the accumulation pattern of uraemic toxins in childhood CKD.

摘要

背景

儿童慢性肾脏病(CKD)的特征是尿毒症毒素的积累,导致多系统紊乱,对生活质量产生负面影响。儿童 CKD 主要由肾小球滤过率(GFR)下降定义,通过单次血清内源性生物标志物(如肌酐)测量来估计(eGFR)。本研究旨在评估 eGFR 在儿科 CKD 队列中预测尿毒症毒素浓度的准确性。

方法

在 65 名 CKD 儿童(10.8[5.1;14.7]岁)中,测定血清中小溶质(尿酸[UA]、尿素、对称二甲基精氨酸[SDMA]、不对称二甲基精氨酸[ADMA])、中分子(β2-微球蛋白[β2M]、补体因子 D [CfD])和蛋白结合溶质(对羟苯甲酰葡糖醛酸[pCG]、马尿酸、吲哚乙酸、吲哚硫酸[IxS]、对羟苯甲酰硫酸[pCS]和 3-羧基-4-甲基-5-丙基-呋喃丙酸[CMPF])的浓度。计算 Spearman 相关系数(r),以将尿毒症毒素浓度与基于血清肌酐或β2M 的三种不同 eGFR 方程相关联。

结果

更新后的 Schwartz eGFR 与肌酐(r=-0.98)、尿素(r=-0.84)、SDMA(r=-0.82)和中分子 CfD 和β2M(均 r=-0.90)的浓度相关性较好。相比之下,CMPF(r=-0.32)、UA(r=-0.45)、ADMA(r=-0.47)和 pCG(r=-0.48)的相关系数较差。所有其他蛋白结合毒素的 r 值在-0.75 到-0.57 之间。三种评估的 eGFR 方程与尿毒症毒素浓度之间存在类似的相关性。

结论

本研究表明,eGFR 对儿童 CKD 中蛋白结合尿毒症毒素、UA 和 ADMA 的浓度预测不佳。因此,eGFR 仅部分反映了儿童 CKD 中尿毒症毒素积累模式的复杂性。

相似文献

1
Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease.在患有慢性肾病的儿科患者中,估计肾小球滤过率(eGFR)只能部分反映尿毒症毒素的蓄积。
Pediatr Nephrol. 2018 Feb;33(2):315-323. doi: 10.1007/s00467-017-3802-5. Epub 2017 Sep 22.
2
Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population.健康儿童与非透析慢性肾脏病儿童人群中代表性尿毒症毒素的浓度。
Nephrol Dial Transplant. 2018 Jun 1;33(6):978-986. doi: 10.1093/ndt/gfx224.
3
Association of advanced age with concentrations of uraemic toxins in CKD.老年与慢性肾脏病中尿毒症毒素浓度的关联。
J Nephrol. 2016 Feb;29(1):81-91. doi: 10.1007/s40620-015-0195-z. Epub 2015 Apr 10.
4
Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population.尿毒症毒素浓度与儿科血液透析人群的残余肾功能相关。
Toxins (Basel). 2019 Apr 24;11(4):235. doi: 10.3390/toxins11040235.
5
Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?Kt/V(urea) 充足性参数是否反映血液透析患者尿毒症毒素的浓度?
PLoS One. 2013 Nov 13;8(11):e76838. doi: 10.1371/journal.pone.0076838. eCollection 2013.
6
A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients.一种新型 UPLC-MS-MS 方法,用于同时测定慢性肾脏病患者中与心血管相关的七种尿毒症潴留毒素。
Anal Bioanal Chem. 2013 Feb;405(6):1937-47. doi: 10.1007/s00216-012-6636-9. Epub 2013 Jan 11.
7
Dietary fibre intake is low in paediatric chronic kidney disease patients but its impact on levels of gut-derived uraemic toxins remains uncertain.儿科慢性肾脏病患者膳食纤维摄入量低,但它对肠道来源尿毒症毒素水平的影响仍不确定。
Pediatr Nephrol. 2021 Jun;36(6):1589-1595. doi: 10.1007/s00467-020-04840-9. Epub 2021 Jan 2.
8
Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.探索不同阶段慢性肾脏病患者及血液透析期间尿毒症毒素的蛋白结合情况。
Toxins (Basel). 2015 Sep 28;7(10):3933-46. doi: 10.3390/toxins7103933.
9
Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.透析过程中蛋白结合型尿毒症毒素的清除:溶质特性及透析膜的作用
Nephrol Dial Transplant. 2000 Jan;15(1):50-7. doi: 10.1093/ndt/15.1.50.
10
Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?对甲酚葡萄糖醛酸苷对死亡率的影响是否与其他蛋白结合型尿毒症毒素相同?
PLoS One. 2013 Jun 24;8(6):e67168. doi: 10.1371/journal.pone.0067168. Print 2013.

引用本文的文献

1
The Non-Traditional Cardiovascular Culprits in Chronic Kidney Disease: Mineral Imbalance and Uremic Toxin Accumulation.慢性肾脏病中非传统的心血管致病因素:矿物质失衡与尿毒症毒素蓄积
Int J Mol Sci. 2025 Aug 17;26(16):7938. doi: 10.3390/ijms26167938.
2
A Systematic Review of Uremic Toxin Concentrations and Cardiovascular Risk Markers in Pediatric Chronic Kidney Disease.儿童慢性肾脏病中尿毒症毒素浓度与心血管风险标志物的系统评价。
Toxins (Basel). 2024 Aug 8;16(8):345. doi: 10.3390/toxins16080345.
3
Developmental dynamics of homoarginine, ADMA and SDMA plasma levels from birth to adolescence.

本文引用的文献

1
Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population.健康儿童与非透析慢性肾脏病儿童人群中代表性尿毒症毒素的浓度。
Nephrol Dial Transplant. 2018 Jun 1;33(6):978-986. doi: 10.1093/ndt/gfx224.
2
Cardiovascular Phenotypes in Children with CKD: The 4C Study.CKD 患儿的心血管表型:4C 研究。
Clin J Am Soc Nephrol. 2017 Jan 6;12(1):19-28. doi: 10.2215/CJN.01090216. Epub 2016 Nov 8.
3
How to use… serum creatinine, cystatin C and GFR.如何使用……血清肌酐、胱抑素C和肾小球滤过率。
从出生到青春期期间同型精氨酸、ADMA 和 SDMA 血浆水平的发育动态。
Amino Acids. 2023 Oct;55(10):1381-1388. doi: 10.1007/s00726-023-03318-w. Epub 2023 Aug 30.
4
CARPEDIEM® for continuous kidney replacement therapy in neonates and small infants: a French multicenter retrospective study.用于新生儿和小婴儿持续肾脏替代治疗的CARPEDIEM®:一项法国多中心回顾性研究。
Pediatr Nephrol. 2023 Aug;38(8):2827-2837. doi: 10.1007/s00467-022-05871-0. Epub 2023 Jan 10.
5
Asymmetric and Symmetric Dimethylarginines as Renal Function Parameters in Paediatric Kidney Diseases: A Literature Review from 2003 to 2022.不对称和对称二甲基精氨酸作为儿科肾脏疾病肾功能参数的研究:2003年至2022年文献综述
Children (Basel). 2022 Oct 31;9(11):1668. doi: 10.3390/children9111668.
6
Low-molecular weight inhibitors of the alternative complement pathway.替代补体途径的低分子量抑制剂。
Immunol Rev. 2023 Jan;313(1):339-357. doi: 10.1111/imr.13143. Epub 2022 Oct 11.
7
Dimethylarginines in Children after Anti-Neoplastic Treatment.儿童抗肿瘤治疗后的二甲基精氨酸。
Medicina (Kaunas). 2022 Jan 11;58(1):108. doi: 10.3390/medicina58010108.
8
Chronic Kidney Disease-Associated Itch (CKD-aI) in Children-A Narrative Review.儿童慢性肾脏病相关性瘙痒(CKD-aI):一篇综述。
Toxins (Basel). 2021 Jun 29;13(7):450. doi: 10.3390/toxins13070450.
9
Serum Myo-Inositol, Dimethyl Sulfone, and Valine in Combination with Creatinine Allow Accurate Assessment of Renal Insufficiency-A Proof of Concept.血清肌醇、二甲基砜和缬氨酸联合肌酐可准确评估肾功能不全——概念验证
Diagnostics (Basel). 2021 Feb 3;11(2):234. doi: 10.3390/diagnostics11020234.
10
Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.血液透析患者的蛋白结合型尿毒症毒素与残余肾功能相关,不受对流传输影响,与预后无关。
Toxins (Basel). 2020 Apr 7;12(4):234. doi: 10.3390/toxins12040234.
Arch Dis Child Educ Pract Ed. 2017 Feb;102(1):37-43. doi: 10.1136/archdischild-2016-311062. Epub 2016 Sep 19.
4
The rebirth of interest in renal tubular function.对肾小管功能兴趣的再度兴起。
Am J Physiol Renal Physiol. 2016 Jun 1;310(11):F1351-5. doi: 10.1152/ajprenal.00055.2016. Epub 2016 Mar 2.
5
A Review of Pediatric Chronic Kidney Disease.小儿慢性肾脏病综述
Blood Purif. 2016;41(1-3):211-7. doi: 10.1159/000441737. Epub 2016 Jan 15.
6
Future Avenues to Decrease Uremic Toxin Concentration.未来降低尿毒症毒素浓度的途径。
Am J Kidney Dis. 2016 Apr;67(4):664-76. doi: 10.1053/j.ajkd.2015.08.029. Epub 2015 Oct 21.
7
Slow intestinal transit contributes to elevate urinary p-cresol level in Italian autistic children.肠道蠕动缓慢导致意大利自闭症儿童尿中对甲酚水平升高。
Autism Res. 2016 Jul;9(7):752-9. doi: 10.1002/aur.1571. Epub 2015 Oct 6.
8
Beta-2 microglobulin-based equation for estimating glomerular filtration rates in Japanese children and adolescents.用于估算日本儿童和青少年肾小球滤过率的基于β2微球蛋白的方程。
Clin Exp Nephrol. 2015 Jun;19(3):450-7. doi: 10.1007/s10157-014-1015-9. Epub 2014 Aug 1.
9
Dimethylarginines ADMA and SDMA: the real water-soluble small toxins?二甲基精氨酸ADMA和SDMA:真正的水溶性小毒素?
Semin Nephrol. 2014 Mar;34(2):97-105. doi: 10.1016/j.semnephrol.2014.02.003. Epub 2014 Feb 17.
10
A new equation to estimate the glomerular filtration rate in children, adolescents and young adults.一种新的估算儿童、青少年和青年肾小球滤过率的方程。
Nephrol Dial Transplant. 2014 May;29(5):1082-91. doi: 10.1093/ndt/gft277. Epub 2013 Sep 17.